Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $2.25 million. The enterprise value is -$1.61 million.
| Market Cap | 2.25M |
| Enterprise Value | -1.61M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 4.51 million shares outstanding. The number of shares has increased by 714.58% in one year.
| Current Share Class | 4.51M |
| Shares Outstanding | 4.51M |
| Shares Change (YoY) | +714.58% |
| Shares Change (QoQ) | +2.97% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 1.50% |
| Float | 4.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.61 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.01
| Current Ratio | 3.01 |
| Quick Ratio | 2.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -561.90 |
Financial Efficiency
Return on equity (ROE) is -1,307.06% and return on invested capital (ROIC) is -288.10%.
| Return on Equity (ROE) | -1,307.06% |
| Return on Assets (ROA) | -171.49% |
| Return on Invested Capital (ROIC) | -288.10% |
| Return on Capital Employed (ROCE) | -285.25% |
| Weighted Average Cost of Capital (WACC) | 11.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.36M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -205,912 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.55% in the last 52 weeks. The beta is 1.25, so Oragenics's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -51.55% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 36.09 |
| Average Volume (20 Days) | 33,022 |
Short Selling Information
The latest short interest is 788,923, so 17.49% of the outstanding shares have been sold short.
| Short Interest | 788,923 |
| Short Previous Month | 783,091 |
| Short % of Shares Out | 17.49% |
| Short % of Float | 17.83% |
| Short Ratio (days to cover) | 34.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.42M |
| Operating Income | -10.47M |
| Pretax Income | -10.29M |
| Net Income | -10.08M |
| EBITDA | n/a |
| EBIT | -10.47M |
| Earnings Per Share (EPS) | -$2.51 |
Balance Sheet
The company has $3.86 million in cash and no debt, with a net cash position of $3.86 million or $0.86 per share.
| Cash & Cash Equivalents | 3.86M |
| Total Debt | n/a |
| Net Cash | 3.86M |
| Net Cash Per Share | $0.86 |
| Equity (Book Value) | 3.67M |
| Book Value Per Share | 0.81 |
| Working Capital | 3.67M |
Cash Flow
| Operating Cash Flow | -10.21M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -3.00M |
| Free Cash Flow | -10.21M |
| FCF Per Share | -$2.26 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Oragenics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -714.58% |
| Shareholder Yield | -714.58% |
| Earnings Yield | -447.86% |
| FCF Yield | -453.36% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 3, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |